What are the pros and cons of the freedom of leading your own company? That’s one of the things that Paul Garafolo talks about in today’s interview.
Paul is CEO of Locus Biosciences, an emerging biotechnology company focused on the discovery and development of precision medicines using CRISPR-Cas technologies. Listen to the episode to learn more about what Paul is doing with CRISPR technology, what applications exist for his company’s technology, and what Paul wishes he’d done differently.
Topics Discussed in Today’s Episode:
- How Paul came to his position as CEO of Locus
- What CRISPR technology is and how it works
- How Locus applies ethical considerations
- Other areas Locus envisions their technology will be applicable beyond infectious disease
- Reflection on what Paul could have done differently
- Paul's thoughts on the difference between running a company vs. working as an employee of a company
- How Paul manages the perspectives of different stakeholders in the company
- Key characteristics that Paul wants to bring into Locus
Resources:
You Might Like
